NTBLQ (Notable Labs) OCF Margin %: -185,500.00% (As of Jun. 2024)


What is Notable Labs OCF Margin %?

Notable Labs NTBLQ -90.00% OCF Margin % is -185,500.00% as of Jun. 2024.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Notable Labs's Cash Flow from Operations for the three months ended in Jun. 2024 was $-3.71 Mil. Notable Labs's Revenue for the three months ended in Jun. 2024 was $0.00 Mil. Therefore, Notable Labs's OCF Margin % for the quarter that ended in Jun. 2024 was -185,500.00%.

As of today, Notable Labs's current OCF Yield % is -2,709,100.00%.

The historical rank and industry rank for Notable Labs's OCF Margin % or its related term are showing as below:

NTBLQ' s OCF Margin % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: -242366.67


NTBLQ's OCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -66.52 vs NTBLQ: -242366.67


Notable Labs OCF Margin % Related Terms


Notable Labs OCF Margin % Historical Data

* Premium members only.

The historical data trend for Notable Labs's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Notable Labs OCF Margin % Chart

Notable Labs Annual Data
Trend Dec21 Dec22 Dec23
OCF Margin %
-5,281.75 -145,525.00 -4,424.52

Notable Labs Quarterly Data
Dec21 Dec22 Mar23 Jun23 Dec23 Mar24 Jun24
OCF Margin % Get a 7-Day Free Trial 0.00 0.00 0.00 -356,100.00 -185,500.00

NTBLQ vs VRTX, REGN, ALNY: OCF Margin % Comparison

For the Biotechnology subindustry, Notable Labs's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Notable Labs OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Notable Labs's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Notable Labs's OCF Margin % falls into.



Notable Labs OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Notable Labs's OCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-13.716/0.31
=-4,424.52 %

Notable Labs's OCF Margin for the quarter that ended in Jun. 2024 is calculated as

OCF Margin=Cash Flow from Operations (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=-3.71/0.002
=-185,500.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -185,500.00% mean?
Notable Labs (NTBLQ) has a OCF Margin % of -185,500.00% as of Jun. 2024. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Notable Labs and its competitors.
Is Notable Labs' OCF Margin % too high?
Notable Labs' current OCF Margin % is -185,500.00%.
How does Notable Labs' OCF Margin % compare to VRTX and REGN?
Notable Labs' OCF Margin % of -185,500.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Notable Labs and its competitors. Notable Labs's current OCF Margin % is -185,500.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Notable Labs stock overvalued right now?
Notable Labs (NTBLQ) has a current OCF Margin % of -185,500.00%. The current OCF Margin % is -185,500.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Notable Labs (NTBLQ), the current OCF Margin % is -185,500.00% as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Notable Labs Business Description

Address 320 Hatch Drive, Foster City, CA, USA, 94404
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. PPMP is designed to enable Notable to identify and select patients expected to be clinically responsive before the initiation of their treatment and potentially enable fast-track therapeutic development in this patient population.